1 Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress.

2 Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta-analysis.

3 Adverse childhood experiences and alexithymia in patients with major depressive disorder.

4 Similar clinical improvement of depression using 0.5-ms and 1-ms pulse widths in bilateral electroconvulsive therapy.

5 whole brain resting-state analysis reveals decreased functional connectivity in major depression

6 psychomotor retardation in untreated depressed elderly

7 p300 latency as an indicator of severity in major depressive disorder

8 diminution of heart rate variability in bipolar depression

9 terapia analítico-comportamental da depressão: uma antiga ou uma nova ciência aplicada? behavior-analytical therapy of depression: an old or a new applied science?

10 problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward

11 Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.

12 Major depression and psychiatric comorbidity in Turkish children and adolescents with cystic fibrosis.

13 The impact of maternal major depression, anxiety disorders and their comorbidities on gestational age, birth weight, preterm birth and low birth weight in newborns.

14 Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process.

15 Cytoimmunological changes and treatment response in major depression

16 Predictors of response to sertraline in elderly major depression

17 Response conflict and frontocingulate dysfunction in unmedicated participants with major depression

18 Paroxetine in Major Depression: Correlating Plasma Concentrations and Clinical Response

19 Association of PDE11A global haplotype with major depression and antidepressant drug response

20 Diurnal Variation in Methylphenidate Stimulant Response in Major Depression

21 The specificity of disorders in the inflammatory response system in major depression

22 Activation of the inflammatory response system (IRS) in major depression

23 Predictors of treatment response in major depression

24 Dexamethasone suppression test response in major depression: Stability across hospitalizations

25 TRH-TSH test and DST in major depression and response to antidepressant treatment

26 2OH-Desipramine and desipramine plasma levels and therapeutic response in major depression

27 UFC as a predictor of response in major depression with psychotic features

28 Body temperature, pituitary-thyroid axis, and the antidepressant response to sleep deprivation in major depression

29 Neurochemistry and paroxetine response in major depression

30 Predictors of response to SSRIs in patients with major depression

31 P.2.133 Antidepressant drug combination from treatment initiation to improve therapeutic response in major depression

32 Hypothalamic-Pituitary-Adrenal Axis Activity and Tricyclic Response in Major Depression

33 Α Review on the Acute Phase Response in Major Depression

34 [Use of Modafinil in Co-existing Major Depression and ErectileDysfunction: A Case Report].

35 Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.

36 Symptomatology differences of major depression in psychiatric versus general hospitals: A machine learning approach

37 Effectiveness of adjuvant occupational therapy in employees with Major Depression: a randomized controlled trial

38 GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

39 Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present.

40 Agomelatine in the treatment of major depression and depression-associated sleep disorders

41 Neuroticism Predicts Subsequent Risk of Major Depression for Whites but Not Blacks

42 No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.

43 The influence of age, sex and education on the phenomenology of depressive symptoms in a population-based sample aged 75+ years with major depression: the Pietà Study

44 Major Depression: Studie zur Wirksamkeit von SAGE-217 durchgeführt

45 Transtorno de estresse pós-traumático e depressão maior Posttraumatic stress disorder and major depression

46 Diagnostic Consistency of Major Depression With Psychosis Across 10 Years

47 Interpersonal Psychotherapy and Antidepressant Medication: Evaluation of a Sequential Treatment Strategy in Women With Recurrent Major Depression

48 The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

49 the effectiveness of group cognitive hypnotherapy on major depression referred to residential and semi-residential addiction recovery centers

50 epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression

51 disorder-specific characteristics of borderline personality disorder with co-occurring depression and its comparison with major depression: an fmri study with emotional interference task

52 the criterion validity of the web-based major depression inventory when used on clinical suspicion of depression in primary care

53 antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients

54 is placebo useful in the treatment of major depression in clinical practice?

55 determining the role of gender in relation between sexual desire and quality of life in patients with major depression

56 age-associated decrease in global dna methylation in patients with major depression

57 association analysis between variants of the interleukin-1&beta; and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

58 symptom profile and severity in a sample of nigerians with psychotic versus nonpsychotic major depression

59 the strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients

60 surface-based regional homogeneity in first-episode, drug-naïve major depression: a resting-state fmri study

61 the comparison of perfectionism components among patients with obsessive - compulsive, major depression disorders, and normal people

62 risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study

63 Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression: Systematic Review and Meta-Analysis

Keyword Connections

Journals

Research Groups

Bibliographies